Register an account to search through 14,000+ stocks! 

Ad

REPH – Recro Pharma Inc

Ad

✘ NOT COMPLIANT

—X—

Pharmaceuticals | USA

Business: PASS

Recro Pharma Inc has cleared the Business screen. Its business activity is compliant with the Shariah standard. If you find this result mistaken or questionable, let us know in the comments.

Financials: FAIL

The financials fail all the three standards we check against.

FTSE

Debt/A105.95%
Cash/A22.98%
(AR+C)/A22.98%

AAOIFI

Debt/MC133.25%
Cash/MC%

DJIM

Debt/24MC104.75%
Cash/24MC22.72%
AR/24MC%

Total Analysts: 3

Recommendation Rating

1.3

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 5.5

Low: 3

High: 6

Market cap82228449
Assets103415000
Dividends per Share
Revenue Growth-33

Recro Pharma, Inc. is a contract development and manufacturing organization (CDMO). The Company is engaged in solving formulation and manufacturing challenges for companies developing oral solid dose drug products. It also focuses on developing sterile injectables oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes and nano/microparticles. It operates in one segment. It provides support services capabilities, which includes preparation of clinical trial supplies, specialized services for the development and Good Manufacturing Practices (GMP) of products, as well as aseptic fill/finish and lyophilization. The Company develops and/or manufactures various products, such as Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM and Verapamil SR. Its manufacturing and development capabilities include formulation, product development through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms.

✘ FTSE✘ AAOIFI✘ DJIM

✘ NOT COMPLIANT

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan.

Ad

Responses